Jul 09, 2009, 05.45 PM IST

GSK Pharma Q1 PAT seen up at Rs 128 cr: IIFL

IIFL has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithkline Pharma's June quarter sales is expected to go up by 36% to Rs 454.4 crore on YoY basis.

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
IIFL has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithkline Pharma 's June quarter sales is expected to go up by 36% to Rs 454.4 crore on YoY basis.


The company's PAT (profit after tax) is expected to go up 11.5% to Rs 128 crore on YoY basis.


Set email alert for

Overview: Intel Haswell platform
Monsoon live: Water level of Yamuna recedes marginally "Monsoon live: Water level of Yamuna recedes marginally"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

Jun 19 2013, 23:15

Buy quality NBFCs with a shot at setting up a bank: Motilal

- in MARKET OUTLOOK

Jun 19 2013, 12:44

Weak rupee to benefit export oriented IT cos: Dipan Mehta

- in MARKET OUTLOOK